AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Letrozole in Nigeria
6 products registered with NAFDAC — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Letromine 2.5 mg Tablet** Tablet | A4-101022 | Carrot-Top Drugs Ltd | active | 24 Sept 2029 |
| Xylox 2.5 Tablet** Tablet | A4-100738 | AnnyGod Pharmaceutical Company Ltd | active | 27 Feb 2029 |
| Letrozole USP 2.5 mg** Tablet | B4-7740 | Hetero Labs Nigeria Limited | active | 20 Dec 2028 |
| Letrozole 2.5mg Tablet** Tablet | B4-7680 | Novartis Nigeria Limited | active | 24 May 2028 |
| Glotraz Tablet** Tablet | C4-1791 | Uche St. Pharmaceutical Company Limited | active | 2 Aug 2026 |
| Femara Film Coated Tablet** Tablet | A4-3436 | Novartis Nigeria Limited | active | 20 Dec 2025 |
Letrozole — NAFDAC Registration Details
NAFDAC (Nigeria) has 6 registered products containing Letrozole, of which 6 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Letrozole registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.